Extended Experimental Procedures
In vitro differentiation
To induce spontaneous differentiation of iPSCs, iPSC clones that showed ESC-like proliferation and morphology were induced to form EBs using the hanging-drop method. CCE mESCs (Keller et al., 1993; Robertson et al., 1986 ) (StemCell Technologies) served as a control. On day 3, EBs were transferred to gelatin-coated 6-well plates and cultured with EB medium (DMEM, 15% FBS, MEM-NEAA, L-glutamine, MTG) for another 11 days. On day 14, cells were fixed with 4% paraformaldehyde (PFA) for immunostaining with the following antibodies: anti-AFP (R&D Systems, MAB1368), anti-β III tubulin (Abcam, ab7751), and anti-α-actinin (Sigma, A7811).
For spontaneous differentiation of human iPSCs, hiPSC clones were cultured in hESC medium (DMEM/F12, 20% KOSR, L-glutamine, MEM-NEAA, β-mercaptoethanol, 8 ng/ml bFGF) on irradiated CF-1 feeder layers and fed every day until ready for EB formation. To initiate EBmediated differentiation, hiPSCs were washed with 1X PBS and incubated with 1 mg/ml dispase in DMEM/F12 for 5 min at 37°C. After scraping to small clumps, hiPSC colonies were washed twice with hEB medium (DMEM/F12, 10% FBS, L-glutamine) by sedimentation and plated on 6-well ultra-low attachment plates. hEB medium was changed every other day by sedimentation.
On day 7, the colonies were plated in 0.1% gelatin-coated 6-well plates and cultured for an additional 7 days. On day 14, cells were fixed with 4% PFA for immunostaining.
Immunostaining
Established iPSC clones were fixed in 4% PFA and permeabilized by 0.1% Triton X-100 in PBS.
Cells were then blocked in 5% BSA in PBS containing 0.1% Triton X-100 for 1 h at room temperature. Primary antibodies anti-mNanog (Bethyl Lab, IHC00205) and anti-h/mSSEA1 (R&D Systems, MAB2156) were diluted between 1:100 and 1:400 in 2.5% BSA PBS containing 0.1% Triton X-100, according to the manufacturer's suggestion. Secondary antibody was diluted 1:400 and cells were stained for 45 min at room temperature. MEFs were plated on 0.1% gelatincoated 12-well plates and transfected with 50 nM siRNA by Lipofectamine 2000 following the manufacturer's protocol. After 72 h, cells were fixed in 3.75% formaldehyde in PBS for 15 min on ice and permeabilized in 0.5% Triton X-100 in PBS. After blocking with 3% milk in PBS for 30 min, cells were stained for F-actin with rhodamine-conjugated phalloidin (Bitium Inc., #00027) at 1:40 dilution or with Hoechst 33342, trihydrochloride, trihydrate (Invitrogen, H3570) at 1:5,000 dilutions. To assess cytoskeletal rearrangement during reprogramming, MEFs were plated in 12-well plates at 4 × 10 4 cells/well. One day later, cells were transduced with 4F virus followed by lentivirus medium containing empty vector pLKO.1 or vectors expressing shRNAs targeting mouse TESK1 or LIMK2. Lentivirus was produced in 293FT cells as described above.
Cells were fixed either immediately after addition of the lentivirus (day 0) or on days 2, 4, or 6, and immunostained with rhodamine-conjugated phalloidin, as described above.
Correlative Light and electron microscopy
MEFs were grown for 2-3 days on 4/2 carbon-coated finder grids (Quantifoil, GMBH).
Epifluorescence images of fixed cells were acquired on an inverted light microscope (Eclipse TE 2000-U, Nikon) equipped with a manually controlled shutter, filter wheels, and a 14-bit cooled CCD camera (Orca II, Hamamatsu) controlled by MetaMorph software (Universal Imaging Corp.) by a Plan Fluor ELWD 40x/0.60 Ph2 or Plan Fluor 10x/0.30 Ph1 objective lens (Nikon).
Viewing a large number of cells on a single grid, by using the grid finders, allows for localization of the exact individual cell in both light and in electron microscope imaging. Cells expressing control shRNA or shTESK1 were chemically fixed in CB containing 4% PFA, washed, and stained with aqueous 2% OsO 4 and 2% uranyl acetate. Dehydration in increasing concentrations of reagent-grade ethanol (15%, 20%, 50%, 70%, 95%, and 100%; 3 min per change) was followed by drying from liquid CO 2 by the critical-point method according to previously described methods (Anderson, 1951; Buckley and Porter, 1975) . Images were obtained under low-dose conditions with a Tecnai G2 F20 microscope (FEI company) equipped with FEG operated at 200keV. Kodak SO-163 plates were developed for 13 min by using D19 developer (Eastman Kodak Co., Rochester, NY).
Expression vectors for TESK1, COF-WT-GFP, and COF-S3A-GFP
TESK1 cDNA was cloned with or without an N-terminal HA-tag into either the pMX retroviral vector or the pCDNA3.1 vector. The PCR-amplified 1.8 kb cDNA was inserted into BamHI and XhoI restriction enzyme sites. An internal SacI restriction site in the TESK1 cDNA sequence was used to clone the entire sequence in two parts. The following primers were used for cloning: Part 1:   HA-tagged TESK1, fwd: 5′-AATTGGATCCATGTACCTTATGATGTGCCGGATTATGCCATGGCCGGGGAACGGCCG   CC-3′OR; BamH1-Tesk fwd: 5′-ATATATATGGATCCATGGCCGGGGAACGGCCGCC-3′; and TESK1, set 1, rev: 5′-GCGATGAGCTCACAGAGGACGATCCCGAAG-3′ Part 2: TESK1, set 2, fwd: 5′-CCAGAGGTGTTGCGGGGAGAGCTGTATGAT-3′ Xho1-TESK1 Rev: 5′-AATTCTCGAGCTAAGAGCGTGCCCCAGGCAGCTG CA-3′ GFP tagged wild-type (COF-WT-GFP) and the phosphorylation site mutant COF (COF-S3A-GFP) were PCR amplified from pCDNA Cof-WT-GFP or pCDNA Cof-S3A-GFP (Delorme et al., 2007) , respectively, using the primers, hsa-Hind III-Cof-WT-Fw (GATCAAGCTTATGGCCTCCGGTGTGGCTGTCTCT) or hsa-Hind III-Cof MutS3A-Fw (GATCAAGCTTATGGCCGCCGGTGTGGCTGTCTCTG) and hsa-XhoI-Cof-Rv (GATCCTCGAGCAAAGGCTTGCCCTCCAGGGAGATG). The amplified fragments were digested and cloned into pMX vector.
For overexpression of TESK1, HA-TESK1, and COF proteins, MEFs were transduced with the pMX retroviral vector as described above.
Human iPSC generation and characterization
Fibroblast culture medium: DMEM, 10% FBS, 1 mM of NEAA. iPSC culture medium: DMEM/F12, 20% Knockout TM Serum Replacement, 1 mM NEAA, 5 mM β-mercaptoethanol, 1x anti-anti, 10 ng/mL bFGF. Ectoderm differentiation media: DMEM/F12, 20% Knockout TM Serum Replacement, 1 mM NEAA, 5 mM β-mercaptoethanol, and 2 µM each of dorsomorphin (iGentBio ), A83-01 (Tocris), and PNU 74654 (Tocris). Mesoderm differentiation medium: DMEM/F12, 20% FBS, NEAA. Endoderm differentiation medium: DMEM/F12, 0.5% FBS, 50 ng/ml Activin A, and 100 ng/ml Wnt3A (Stem RD). For reprogramming, human foreskin fibroblast (BJ) cells (~0.7 × 10 6 cells) were transfected with non-targeting or TESK1 siRNA (50 pmol) together with the episomal DNA cocktail (Addgene) as described ((Okita et al., 2011; Yu et al., 2009) . Transfected cells were cultured in fibroblast growth medium for 7 days, trypsinized, and re-seeded on CF1 MEF feeders (5 × 10 4 cells/cm 2 ). iPSC cells were maintained in culture media for 5 weeks, then the iPSC colonies were picked and maintained on CF1 MEF feeders for further characterization. The iPSCs were maintained in NutriStem XF/FF culture medium (Stemgent) prior to in vitro differentiation. For ectoderm differentiation, the cells were seeded on Matrigel (BD Biosciences)-coated plates in NutriStem medium for 2-3 days until 50-60% confluent, and then treated with ectoderm differentiation medium for 5-7 days until cell clusters with a neural rosette structure were observed under microscope. For mesoderm differentiation, EBs were formed and maintained in mesoderm differentiation medium in suspension culture in ultra-low attachment plates (Corning Costa) for 6 days, and then transferred to wells coated with 0.1% gelatin (Stem Cell Technologies) in the same medium for an additional 6-8 days until the beating colonies were observed. For endoderm differentiation, the cells were treated with Accutase to yield single cells and seeded on Matrigel-coated plates at 10 4 cells/cm 2 in NutriStem medium for 2-3 days until 50-60% confluent. The cells were then treated with endoderm differentiation medium for 3-5 days before immunostaining.
For teratoma formation, iPSCs were injected into the SCID mice and the tumors were harvested eight weeks later. The tumors were embedded in paraffin, sectioned, and stained with H&E. For alkaline phosphatase staining, iPSCs were fixed with 4% PFA (Affymetrix) and stained with an AP staining kit (Vector labs) according to the manufacturer's protocol. For immunostaining, iPSCs were fixed in 4% PFA and stained with antibodies against Oct4, Sox2, Nanog, Tra-1-60, Tra-1-81 (Cell Signaling), and SSEA3 (Millipore). Ectoderm lineage cells were stained with Pax6 (Covance) and Nestin (Abcam), mesoderm lineage cells were stained with α-SMA (Sigma) and α-actinin (Sigma), endoderm cells were stained with Sox17 and FoxA2 (both R&D Systems). CTRL  TESK1  SRPK1  RAGE  STK25  RNASEL  GTF2F1  PKIB  BMPR1A  TBK1  TLK2  IRAK2  PRKCA  MAPK1  AATK  JAK1  EPHA1  PIM2  FRAP1  TRIB3  CAMKV  MAP2K1  KHK  6330514A18RIK  NPR2  MOS  NEK6  PLK2  RPS6KB1  AK3  DGKE  PKIG  PIK3R5  GIT2  PER2  FASTKD5  BUB1B  IRAK3  LIMK2  EPHA5  CDC2L6  SNF1LK  DAPK2  PAK7  CSNK2B  BMP2K  PLK1  SCYL1  UHMK1  PIK3C2G  GALK2  NME1  PIK3AP1  CNKSR3  BMPR2  DDR1  DAPK3  STK24  EIF2AK2 Kinase genes identified as hits in the primary screen were confirmed by secondary and tertiary screens. After the primary screen ( Figure 1B) , kinase genes were grouped by the number of shRNAs targeting a single gene that led to a 2-fold increase in GFP+ colony numbers. Kinases targeted by at least two shRNAs (sh-1 and sh-2) were chosen as candidates for further analysis.
In addition, kinases targeted with a single shRNA were included if they induced a >6-fold increase in GFP+ colony numbers. The grouping of targets based on the primary screen is Similarly in siCOF treated cells, MyoIIb was found on the actin cables (cables marked by broken lines). In siTESK1 treated cells, MyoIIb was found dispersed without forming obvious foci on the actin cables. Human siTESK1-iPSCs differentiate into germ layers in vitro. EBs were formed using the hanging-drop method and allowed to undergo spontaneous differentiation. On day 14, differentiated cells were fixed with 4% PFA and immunostained for SOX17, FOXA2, GATA4, NESTIN, and PAX6. Tables S1, related to Figures 1 and S1   Tables S2, related to Figures 1 and S1   Tables S3, related to Figures 1 and S1 ---role in cell BMPs play a key role in skeletal development and paYerning; expression is increased during BMP--2 induced differen,a,on and the gene product contains a nulcear localiza,on signal. BMPR2 mol func receptor ac,vity; transforming growth factor bata receptor ac,vity; Protein serine/threonine kinase ac,vity;
SUPPLEMENTARY TABLES
----ATP binding; transferase ac,vity role in cell mesoderm forma,on; posi,ve regula,on of endothelial cell prolifera,on; transmembrane receptor protein serine/threonine kinase ac,vity; anterior/posterior paYern forma,on; posi,ve regula,on of pathway-restrected SMAD protein phosphoryla,on; nega,ve regula,on of cell growth; posi,ve regula,on of BMP signaling MAPK1 mol func phosphotyrosine binding; Protein serine/threonine kinase ac,vity; ATP binding; transferase ac,vity; miR125a, miR145, miR149 DNA binding; MAP kinase ac,vity; MAP kinase 2 ac,vity miR202, miR320a role in cell nuclear transloca,on of MAPK; induc,on of apoptosis; response to stress; response to DNA damage s,mulus; cell cycle; signal transduc,on; posi,ve regula,on of cell migra,on; posi,ve regula,on of cell prolifera,on; nega,ve regula,on of cell differen,a,on Table S4 , related to Figures 2 and S2. Functions of six barrier genes in iPSC generation 1 Molecular func,ons of six kinases were determined using GO annota,ons: Molecular func,ons (mol func) and biological process (role in cell). Six kinases listed are: DGKε (NM_019505), PLK2 (NM_152804), TESK1 (NM_011571), BMP2K (NM_080708), BMPR2 (NM_007561), MAPK1 (NM_011949). 2 MicroRNAs that are predicted to target these genes are also listed. 
